Idecabtagene Vicleucel
bms
['car t']
new data being presented by dr. doris hansen shows real-world outcomes of ide-cel car t-cell therapy for #rrmm. visit her poster tomorrow at #asco22. view abstract: 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.